1. Home
  2. CLDX vs TILE Comparison

CLDX vs TILE Comparison

Compare CLDX & TILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • TILE
  • Stock Information
  • Founded
  • CLDX N/A
  • TILE 1973
  • Country
  • CLDX United States
  • TILE United States
  • Employees
  • CLDX N/A
  • TILE N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • TILE Home Furnishings
  • Sector
  • CLDX Health Care
  • TILE Consumer Discretionary
  • Exchange
  • CLDX Nasdaq
  • TILE Nasdaq
  • Market Cap
  • CLDX 1.3B
  • TILE 1.1B
  • IPO Year
  • CLDX 2008
  • TILE N/A
  • Fundamental
  • Price
  • CLDX $16.85
  • TILE $19.87
  • Analyst Decision
  • CLDX Buy
  • TILE Buy
  • Analyst Count
  • CLDX 8
  • TILE 1
  • Target Price
  • CLDX $54.29
  • TILE $30.00
  • AVG Volume (30 Days)
  • CLDX 767.1K
  • TILE 654.1K
  • Earning Date
  • CLDX 05-05-2025
  • TILE 05-02-2025
  • Dividend Yield
  • CLDX N/A
  • TILE 0.21%
  • EPS Growth
  • CLDX N/A
  • TILE 94.74
  • EPS
  • CLDX N/A
  • TILE 1.48
  • Revenue
  • CLDX $7,020,000.00
  • TILE $1,315,658,000.00
  • Revenue This Year
  • CLDX N/A
  • TILE $4.74
  • Revenue Next Year
  • CLDX $27.01
  • TILE $5.30
  • P/E Ratio
  • CLDX N/A
  • TILE $13.41
  • Revenue Growth
  • CLDX 1.99
  • TILE 4.29
  • 52 Week Low
  • CLDX $16.75
  • TILE $14.13
  • 52 Week High
  • CLDX $47.00
  • TILE $27.34
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 29.79
  • TILE 46.51
  • Support Level
  • CLDX $19.48
  • TILE $19.31
  • Resistance Level
  • CLDX $20.38
  • TILE $20.48
  • Average True Range (ATR)
  • CLDX 1.03
  • TILE 0.61
  • MACD
  • CLDX -0.17
  • TILE 0.20
  • Stochastic Oscillator
  • CLDX 2.19
  • TILE 72.61

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.

Share on Social Networks: